Compare TOWN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | AMPH |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | United States |
| Employees | 1251 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 1.2B |
| IPO Year | N/A | 2005 |
| Metric | TOWN | AMPH |
|---|---|---|
| Price | $33.25 | $19.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $30.29 |
| AVG Volume (30 Days) | 419.8K | ★ 592.9K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $35.63 | $7.19 |
| Revenue Next Year | $5.18 | $4.76 |
| P/E Ratio | $16.23 | ★ $9.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.43 | $17.03 |
| 52 Week High | $37.86 | $31.26 |
| Indicator | TOWN | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 37.94 |
| Support Level | $32.21 | $17.03 |
| Resistance Level | $33.97 | $29.30 |
| Average True Range (ATR) | 0.77 | 0.79 |
| MACD | 0.06 | 0.26 |
| Stochastic Oscillator | 48.00 | 84.59 |
Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.